InvestSMART

Acrux Limited (ASX: ACR) - Announcements

Current share price for ACR : $0.011 0.001 (8.33%)+

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Licensing partnership in Saudi Arabia for Dapsone 5%, Gel 31 Jul 2025 9:01AM $0.018 $0.011 fallen by 38.89%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2025 9:03AM $0.018 $0.011 fallen by 38.89%
$6 Receipt of second advance for FY25 R&D Tax Incentive 3 Jul 2025 9:29AM $0.018 $0.011 fallen by 38.89%
$6 Notification of cessation of securities - ACR 3 Jul 2025 9:24AM $0.018 $0.011 fallen by 38.89%
$6 Application for quotation of securities - ACR 3 Jul 2025 9:23AM $0.018 $0.011 fallen by 38.89%
$6 Change in substantial holding 30 Jun 2025 2:58PM $0.017 $0.011 fallen by 35.29%
$6 App 3Z, Kotsanis 2 Jun 2025 9:05AM $0.023 $0.011 fallen by 52.17%
$6 App 3X, Warmbrunn 2 Jun 2025 9:05AM $0.023 $0.011 fallen by 52.17%
$6 Appendix 3Y Brumley 23 May 2025 9:11AM $0.023 $0.011 fallen by 52.17%
$6 Application for quotation of securities - ACR 23 May 2025 9:10AM $0.023 $0.011 fallen by 52.17%
$6 Notification of cessation of securities - ACR 23 May 2025 9:05AM $0.023 $0.011 fallen by 52.17%
$6 Dapsone 7.5%, Gel launched in the United States 9 May 2025 8:33AM $0.023 $0.011 fallen by 52.17%
$6 Acrux CEO and Managing Director appointment 7 May 2025 9:12AM $0.023 $0.011 fallen by 52.17%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 10:03AM $0.023 $0.011 fallen by 52.17%
$6 Details of Share Registry address 9 Apr 2025 12:18PM $0.025 $0.011 fallen by 56%
$6 Appendix 3Y Dobinson 4 Apr 2025 9:11AM $0.023 $0.011 fallen by 52.17%
$6 Application for quotation of securities - ACR 4 Apr 2025 9:08AM $0.023 $0.011 fallen by 52.17%
$6 Acrux receives $1.73m advance on FY25 R&D Tax Incentive 3 Apr 2025 9:32AM $0.023 $0.011 fallen by 52.17%
$6 Attaching Options final application date 31 March 2025 7 Mar 2025 8:18AM $0.027 $0.011 fallen by 59.26%
$6 Notification of cessation of securities - ACR 6 Mar 2025 8:18AM $0.027 $0.011 fallen by 59.26%
$6 Appendix 3Y Dobinson 4 Mar 2025 8:19AM $0.026 $0.011 fallen by 57.69%
$6 Cleansing Notice 3 Mar 2025 5:29PM $0.026 $0.011 fallen by 57.69%
$6 Application for quotation of securities - ACR 3 Mar 2025 5:29PM $0.026 $0.011 fallen by 57.69%
$6 Investor Presentation February 2025 25 Feb 2025 4:54PM $0.024 $0.011 fallen by 54.17%
$6 Investor Webinar Announcement 25 Feb 2025 4:52PM $0.024 $0.011 fallen by 54.17%

51 - 75 of 688 results

Page 3 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.